Patients With Overweight or Obesity Show Significant Weight Loss in Phase 2 Survodutide Trial
After receiving 4.8 mg of survodutide weekly for 46 weeks, more than half of trial participants achieved weight loss of 15% or more.
Related Articles
Gaps in Patient Care for IgA Nephropathy
Panelists discuss how significant gaps in immunoglobulin A (IgA) nephropathy patient care persist, including delayed diagnosis, limited access to nephrology expertise, inadequate disease monitoring, and…
Air Pollution, Obesity Linked to Significant Liver Fibrosis in Patients With MASH
There was no association observed between lower income and increased fibrosis among New York City residents with metabolic dysfunction-associated steatohepatitis (MASH).
CARTITUDE-4 Data Solidify Cilta-cel’s Role in RRMM: Surbhi Sidana, MD, MBBS
Surbhi Sidana, MD, MBBS, director of the Myeloma Disease Focused Group at Stanford University, provides a reintroduction to CARTITUDE-4 and insight on how this phase…
FDA Expands Dupilumab Approval as First New Biologic for Bullous Pemphigoid
Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch…
Teledermatology Shows Promise to Reduce Disparities in Skin Cancer Screening
A teledermatology program in Georgia helped identify patients with skin lesions that warranted in-person follow-up with a physician.
Overview of Different Therapies for Patients with Pulmonary Arterial Hypertension
Panelists discuss how current therapeutic strengths include 15 approved treatments with different mechanisms of action that can work synergistically, while limitations involve variable delivery methods…
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
ACC Advocates Early Medication Use for Obesity to Boost Cardiovascular Health
For patients with obesity, clinicians should move beyond a “try and fail” approach to lifestyle interventions and prioritize weight management medication when it can deliver…
Democratic Doctors Caucus Reaffirms EMTALA Amid Trump’s CMS Policy Reversal on Abortion Care
Democratic leaders assert the Emergency Medical Treatment and Labor Act (EMTALA) remains vital for emergency care, countering confusion from recent policy changes affecting abortion rights…
Two steps for success in value-based oncology care
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.